Moreover, the analysis of RNA activities of additional risk genes such as SORL1 (Maple-Grodem et al., 2018) and PLCG2 (van der Lee et al., 2019, 2020) further enriches our understanding of AD and PD. This evidence concerns the gene PLCG2 and Parkinson disease.